Fukuokaya W, Mori K, Urabe F, Igarashi T, Yanagisawa T, Tsuzuki S, Honda M, Miki K, Kimura T. Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive Prostate Cancer Treated With Abiraterone Acetate. JAMA Netw Open. 2024 Mar 4;7(3):e242467. doi: 10.1001/jamanetworkopen.2024.2467. PMID: 38488793; PMCID: PMC10943414.